HYBRID EVENT: Join us in person in London, UK or attend virtually from anywhere.

8th Edition of Cardiology World Conference

September 27-29, 2027 | London, UK

September 27 -29, 2027 | London, UK
Cardio 2027

Mapping coronary calcium to myocardial perfusion with Fusion CV

James V Cireddu, Speaker at Cardiovascular Conference
Harrington Heart & Vascular Institute, University Hospitals, United States
Title : Mapping coronary calcium to myocardial perfusion with Fusion CV

Abstract:

Coronary artery calcium (CAC) and stress myocardial perfusion address different clinical questions. A patient can have substantial calcified coronary atherosclerosis despite normal stress perfusion, while an equivocal perfusion defect may warrant closer review for attenuation artifact. This keynote examines how low-dose CT attenuation correction (CTAC) images acquired during SPECT/CT or PET/CT myocardial perfusion imaging can add anatomic context to both interpretations.

Fusion CV is an investigational, AI-assisted workflow that uses same-session CTAC data without an additional scan or contrast administration. The first phase is designed to assess CTAC image quality, identify and localize coronary calcium by vessel, estimate calcium burden, and align those findings with myocardial territories on the perfusion polar map. The proposed display and structured report would help physicians review the aligned findings and flag limitations in image quality or registration.

Through illustrative scenarios, the keynote will show how the combined display could bring coronary atherosclerosis into view when perfusion is normal and help readers assess whether the distribution of calcium corresponds to the territory of an equivocal defect. The presentation will also discuss when motion, noise, or incomplete coverage can make a calcium assessment unreliable on low-dose, nongated CT.

Fusion CV is at the proof-of-concept stage. Planned validation will compare CTAC-derived calcium burden categories with dedicated ECG-gated calcium scoring, evaluate vessel-level localization and registration across scanners and protocols, and assess reader agreement and interpretation time. Future work will explore epicardial adipose tissue, stress ECG findings, and clinical variables. The clinical question is whether reviewing coronary calcium and perfusion together improves the consistency of reporting and cardiovascular risk assessment in routine nuclear cardiology.

Biography:

James V. Cireddu, MD, FACC, FASE, FASNC, is an invasive cardiologist and System Director of Nuclear Cardiology and Stress Testing at the Harrington Heart & Vascular Institute, University Hospitals in Cleveland, Ohio. He serves as Medical Director of the Bedford and Richmond campuses and as Clinical Associate Professor of Medicine at Case Western Reserve University School of Medicine. He leads Fusion CV, a collaboration between University Hospitals and Case Western Reserve University developing methods to review coronary calcium and myocardial perfusion together.

Whatsapp